NASDAQ: GENB · Biotechnology
Over the past week, Generate Biomedicines (GENB) logged 14 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 58% bullish but is far apart: Reddit runs 100% bullish while News sits at just 0%. Wall Street is more constructive, with 6 of 6 analysts rating GENB a buy.
There is little buzz around GENB this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 100% buy share sits next to a crowd that ranges from News at 0% to Reddit at 100%. No other tracker puts the two side by side.
Across 6 analysts the consensus is a Strong Buy: 6 buy calls against 0 sell, with an average 12-month price target of $25.60.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 42 points above the crowd average of 58%, the professionals are more constructive than retail. The split is inside the crowd: Reddit reads 100% bullish while News sits at 0%, a 100-point spread that single-source trackers miss.
Over the 30-day window, Generate Biomedicines (GENB) buzz held elevated around 69.8 while the price drifted up 15.3% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 490K shares. Updated Aug 15, 2026. Over the last 7 trading days, GENB gained 12.6%. Buzz activity in the recent week averaged 39.2 and was highly volatile, swinging between 24.7 and 69.8. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 6 of the 8 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for GENB and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live GENB sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 15, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (6 / 0 / 0) |
| Crowd bullish (7d) | 58% |
| Avg price target | $25.60 |
| Most bullish source | Reddit, 100% |
| Most bearish source | News, 0% |
| Sentiment spread | 100 pts |
| Mentions (7d) | 14 |
| Market cap | $2.01B |
| EPS · Beta | -$2.09 · n/a |
| Revenue (TTM) | $26.5M · 0% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Generate Biomedicines (GENB) currently carries an Adanos hold signal with 65/100 conviction. The current cross-source average reads 58% bullish across 3 active sources. Those sources contribute 14 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Generate Biomedicines (GENB) is fairly quiet with 1 mentions over the last 7 days; the 30-day context spans 3 tracked subreddits. The 7-day tone is 100% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bullish on Generate Biomedicines (GENB), averaging 58% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 100% bullish and News at 0%, a 100-point spread. On the professional side, 6 of 6 analysts rate GENB a buy.
Of the 6 analysts covering Generate Biomedicines (GENB), 6 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $25.60. That puts the street ahead of the crowd, which averages 58% bullish.
Generate Biomedicines (GENB)'s cross-source average is bullish at 58% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. Reddit reads 100% bullish, X reads 75% bullish and news coverage is the most negative at 0% bullish. The combined signal points to broad mixed pressure with 65/100 conviction.
The cross-source average is bullish for Generate Biomedicines (GENB) at 58% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. The most bearish reading is news at 0% bullish. 3-day activity momentum is falling across X. The hold signal carries 65/100 conviction.
X is the dominant discussion channel with 12 mentions (86% of total volume). Reddit contributes 1 mention and News contributes 1 mention. The cross-source average is bullish at 58% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. GENB's hold signal at 65/100 conviction reflects a bullish cross-source average at 58% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. It is a research shortcut, not financial advice.
The GENB sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key